Synaptics (SYNA)
(Real Time Quote from BATS)
$97.48 USD
-1.33 (-1.35%)
Updated Mar 28, 2024 03:12 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Synaptics Incorporated falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 1,355 | 1,740 | 1,340 | 1,334 | 1,472 |
Cost Of Goods | 639 | 797 | 728 | 791 | 975 |
Gross Profit | 716 | 943 | 611 | 543 | 497 |
Selling & Adminstrative & Depr. & Amort Expenses | 562 | 593 | 464 | 474 | 503 |
Income After Depreciation & Amortization | 154 | 350 | 147 | 69 | -6 |
Non-Operating Income | 27 | 0 | 3 | 113 | 7 |
Interest Expense | 56 | 30 | 30 | 23 | 21 |
Pretax Income | 126 | 321 | 120 | 159 | -21 |
Income Taxes | 52 | 65 | 31 | 39 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 2 | -9 | -2 | -2 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 74 | 258 | 80 | 119 | -23 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 74 | 258 | 80 | 119 | -23 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 330 | 511 | 308 | 166 | 122 |
Depreciation & Amortization (Cash Flow) | 176 | 161 | 161 | 97 | 128 |
Income After Depreciation & Amortization | 154 | 350 | 147 | 69 | -6 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 40.20 | 40.70 | 38.30 | 34.80 | 34.60 |
Diluted EPS Before Non-Recurring Items | 5.23 | 10.39 | 6.34 | 4.21 | 2.50 |
Diluted Net EPS (GAAP) | 1.83 | 6.33 | 2.08 | 3.41 | -0.66 |
Fiscal Year end for Synaptics Incorporated falls in the month of June .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 237.00 | 237.70 | 227.30 | 326.60 | 353.10 |
Cost Of Goods | 128.00 | 130.60 | 126.10 | 154.30 | 166.40 |
Gross Profit | 109.00 | 107.10 | 101.20 | 172.30 | 186.70 |
SG&A, R&D, and Dept/Amort Expenses | 126.90 | 142.30 | 139.20 | 138.10 | 140.60 |
Income After SG&A, R&D, and Dept/Amort Expenses | -17.90 | -35.20 | -38.00 | 34.20 | 46.10 |
Non-Operating Income | 0.00 | 0.00 | 27.20 | 0.00 | 0.00 |
Interest Expense | 6.10 | 5.40 | 33.50 | 7.00 | 6.70 |
Pretax Income | -24.00 | -40.60 | -44.30 | 27.20 | 39.40 |
Income Taxes | -15.00 | 15.00 | -20.90 | 16.80 | 17.40 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -9.00 | -55.60 | -23.40 | 10.40 | 22.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -9.00 | -55.60 | -23.40 | 10.40 | 22.00 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 39.20 | 38.80 | 39.80 | 39.90 | 40.20 |
Diluted EPS Before Non-Recurring Items | 0.11 | -0.34 | 0.01 | 1.14 | 1.47 |
Diluted Net EPS (GAAP) | -0.23 | -1.43 | -0.57 | 0.26 | 0.55 |